题 目：Molecular Imaging Diseases with Color and Dark Materials
主讲人：程震教授（Prof. Zhen Cheng）
Stanford University
时 间：2016年11月27日上午10：30
地 点：化学化工学院老楼307大会议室
主讲人简介：
程震教授在斯坦福大学医学院分子影像中心、克莱瑞-斯坦福癌症早期检测研究中心、斯坦福癌症研究所、放射科及BioX中心从事研究和教学工作，现为美国斯坦福大学分子影像中心肿瘤分子影像化学实验室主任。长期从事肿瘤分子影像和治疗药物、多模态纳米分子探针的研制和开发，从化学、生物、物理、纳米技术等多种角度进行癌症分子影像研究。例如新的分子探针的开发、肿瘤的早期检测等。
现已发表SCI论文180余篇，其中封面文章9篇。总影响因子大于1000，H因子44；论文被引用次数7300余次(Google Scholar)。多篇论文工作被新闻媒体和专业杂志报道。曾多次被邀请在本专业的国际会议上作大会特邀报告（20多次），担任分会主席等。应邀作为评审专家为多个国际基金，大学或研究机构如美国国立卫生研究院、美国国防部、美国能源部、中国自然科学基金重点项目、德国科研基金会、法国国家研究机构等评选基金申请。同时担任Nanomedicine: Nanotechnology, Biology, and Medicine副主编，Frontiers in Biomedical Physics 副主编，Current Molecular Imaging北美地区总编，多个专业期刊如Clinical Cancer Research, Amino Acid编委及特邀总编，一百多个专业期刊如Nature Nanotechnology，Nature Communications，Angewandte Chemie International Edition，Science Translational Medicine，JACS，Cancer Research, JNM等的审稿人。
2012-2014年任美国核医学及分子影像学会放射性药物委员会董事会董事，现担任中美核医学会和分子影像学会主席，2009年为美国国立癌症研究所图像引导给药白皮书工作组成员。研究项目受到美国国立卫生研究院，国防部，能源部等基金的支持，先后主持或参与20多个科研项目。
与国际上众多院校有着密切的学术合作交流，多次在新加坡南洋理工大学、普渡大学、加州大学、香港中文大学、多伦多大学等国际知名大学进行访问讲学和学术合作。
Prof. Cheng is the director of Cancer Molecular Imaging Chemistry Laboratory (CMICL), Molecular Imaging Program at Stanford and Bio-X Program Canary Center at Stanford for Cancer Early Detection, Stanford University. The overall objective of Cheng’s laboratory is to develop novel molecular imaging probes and techniques for non-invasive detection of cancer and its metastasis at the earliest stage, so that cancer can be cured or transformed into a chronic, manageable disease. In order to achieve this goal, they aim to identify novel cancer biomarkers with significant clinical relevance, develop new chemistry for probes preparation, and validate new strategies for probes high-throughput screening.
Over 180 SCI papers were published and nine of them are cover papers. Total impact factor is above 1000. H-factor is 44. According to google scholar, published papers have been cited more than 7300 times. Lots of his research works were reported by press and professional journals, and many international conferences in the field of molecular imaging have invited him for academic report (more than 20 times) or as branch chairman. More than one international foundation, institution or universities, such as U.S. National Institutes of Health, U.S. Department of Defense, U.S. Department of Energy, National Natural Science Foundation of China,Research Foundation of German, French National Research Institute, have invited him as assessment expert to evaluate foundation applications. He is also the Deputy Editor of Nanomed.-Nanotechnol. Biol. Med., Front. Biomed. Phys., the North America Chief Editor of Curr. Mol. Imaging, and the editorial board or invited editor-in-chief of many other journals, such asClin.Cancer Res., Amino Acid. He is also the reviewer of more than a hundred journals, such as Nat. Nanotechnol., Nat. Commun., Angew. Chem.-Int. Edit., Sci. Transl. Med., JACS,Cancer Rese., JNM.
He was the director of board of Radiological Drugs Committee of American Society of Nuclear Medicine and Molecular Imaging during 2012-2014. He is currently the chairman of China-U.S. Society of Nuclear Medicine and Molecular Imaging. In 2009, he was the member of the Image Guiding Drug Administration white-book work group of U.S. National Cancer Institute. His research programs are supported by the foundation of U.S. NIH, DOD, DOE, et al, and he has also directed or participated in more than 20 research projects.
Close academic exchanges are performed in many international institutions, such as Nanyang Technological University, Purdue University,University of California, Chinese University of Hong Kong, University of Toronto, et al.
联系人：王怡红 教授
联系方式：15996315308
欢迎大家参加！
